Structural studies of interactions between anticancer platinum drugs and DNA
- 31 December 1996
- journal article
- review article
- Published by Elsevier in Progress in Biophysics and Molecular Biology
- Vol. 66 (1) , 81-111
- https://doi.org/10.1016/s0079-6107(96)00017-x
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Backbone Dynamics of the A-Domain of HMG1 As Studied by 15N NMR SpectroscopyBiochemistry, 1995
- Ixr1, a Yeast Protein That Binds to Platinated DNA and Confers Sensitivity to CisplatinScience, 1993
- DNA conformational change produced by the site-specific interstrand cross-link of trans-diamminedichloroplatinum(II)Biochemistry, 1993
- Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II)Biochemistry, 1993
- Repair synthesis by human cell extracts in cisplatin damaged DNA is preferentially determined by minor adductsNucleic Acids Research, 1992
- DNA unwinding produced by site-specific intrastrand crosslinks of the antitumor drug cis-diamminedichloroplatinum(II)Biochemistry, 1991
- Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum (II)Biochemical Journal, 1991
- Platinum-195 NMR kinetic and mechanistic studies of cis- and trans-diamminedichloroplatinum(II) binding to DNAJournal of the American Chemical Society, 1990
- Intrastrand bis(guanine) chelation of trinucleoside diphosphate d(CpGpG) to cis-platinum: an x-ray single-crystal structure analysisJournal of the American Chemical Society, 1987
- Platinum(II) complexes generate frame-shift mutations in test strains of Salmonella typhimuriumMutation Research/Genetic Toxicology, 1979